Skip to main content
Mykol Larvie, MD, Radiology, Cleveland, OH

Mykol Larvie MD

Neuroradiology, Nuclear Radiology


Director of Functional Neuroimaging

Join to View Full Profile
  • 9500 Euclid AvenueCleveland ClinicCleveland, OH 44195

Dr. Larvie is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Massachusetts General Hospital/Harvard Medical School
    Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiology-Diagnostic, 2004 - 2008
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 2003 - 2004
  • Harvard Medical School
    Harvard Medical SchoolClass of 2003

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2006 - 2027
  • MI State Medical License
    MI State Medical License 2021 - 2027
  • HI State Medical License
    HI State Medical License 2019 - 2026
  • FL State Medical License
    FL State Medical License 2016 - 2025
  • OH State Medical License
    OH State Medical License 2016 - 2024
  • Diagnostic Radiology
    American Board of Radiology Diagnostic Radiology
  • Neuroradiology
    American Board of Radiology Neuroradiology
  • Nuclear Radiology
    American Board of Radiology Nuclear Radiology

Publications & Presentations

PubMed

Journal Articles

  • Quantitative Positron Emission Tomography–Guided Magnetic Resonance Imaging Postprocessing in Magnetic Resonance Imaging–Negative Epilepsies  
    William Bingaman, Guiyun Wu, Mykol Larvie, Imad M Najm, Stephen E Jones, Andreas V Alexopoulos, Epilepsia

Press Mentions

  • New Drug May Help Diagnose MS More Accurately
    New Drug May Help Diagnose MS More AccuratelyJanuary 30th, 2020
  • FDA Approves Clinical Trial for ‘Missing Link’ Imaging Agent Aimed at Faster MS Diagnosis
    FDA Approves Clinical Trial for ‘Missing Link’ Imaging Agent Aimed at Faster MS DiagnosisJanuary 28th, 2020

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: